To buy shares in Astrazeneca Plc you will need a FCA regulated UK stock broker like AJ Bell, Hargreaves Lansdown or interactive investor where it currently costs 11,146p to buy one share in Astrazeneca Plc (as of 18:52 01-Aug-2025). Which is a change of -178p or -1.57% from the last closing price of 11,324p.
How To Buy Astrazeneca Plc Shares
It may seem complicated to buy shares for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Astrazeneca Plc:
- Pick a stock broker (jump down to compare the best brokers for buying Astrazeneca Plc shares)
- Deposit funds (via bank transfer or debit card)
- Search for the company share symbol: (LON:AZN)
- Choose the number of shares you want to buy (1 share currently costs 11,146p)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the shares cheaper if you think the price will go down)
- Track the performance of your Astrazeneca Plc shares in your account (this will show your profit and loss)
- Astrazeneca Plc is currently worth Β£235,139,101,096 based on the last closing price of 11,324p with 2,174,578 shares traded.
- The most recent Astrazeneca Plc daily high has been 11,162p and daily low 10,846p.
- The Astrazeneca Plc share price 52 week high has been 13,388p and the 52 week low 9,573.5p.
Compare Brokers For Buying Astrazeneca Plc Stock
Is Now A Good Time To Buy Astrazeneca Plc Stock?
- Astrazeneca Plc’s EPS (earnings per share) are 4.02. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Astrazeneca Plc’s PE (price earnings ratio) is 27.71. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Astrazeneca Plc share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.